These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12957377)

  • 1. Engineering of RNase P ribozyme for gene-targeting applications.
    Raj SM; Liu F
    Gene; 2003 Aug; 313():59-69. PubMed ID: 12957377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing RNase P ribozymes for gene-targeting and antiviral therapy.
    Trang P; Kim K; Liu F
    Cell Microbiol; 2004 Jun; 6(6):499-508. PubMed ID: 15104592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture.
    Kilani AF; Trang P; Jo S; Hsu A; Kim J; Nepomuceno E; Liou K; Liu F
    J Biol Chem; 2000 Apr; 275(14):10611-22. PubMed ID: 10744757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gene expression in human cells using RNase P-derived ribozymes and external guide sequences.
    Kim K; Liu F
    Biochim Biophys Acta; 2007; 1769(11-12):603-12. PubMed ID: 17976837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclease footprint analyses of the interactions between RNase P ribozyme and a model mRNA substrate.
    Trang P; Hsu AW; Liu F
    Nucleic Acids Res; 1999 Dec; 27(23):4590-7. PubMed ID: 10556315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of an RNase P ribozyme against the mRNA encoding human cytomegalovirus protease inhibits viral capsid protein processing and growth.
    Trang P; Kim K; Zhu J; Liu F
    J Mol Biol; 2003 May; 328(5):1123-35. PubMed ID: 12729746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of the protein cofactor on the interactions between an RNase P ribozyme and its target mRNA substrate.
    Hsu AW; Kilani AF; Liou K; Lee J; Liu F
    Nucleic Acids Res; 2000 Aug; 28(16):3105-16. PubMed ID: 10931926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General design and construction of RNase P ribozymes for gene-targeting applications.
    Zou H; Chan K; Trang P; Liu F
    Methods Mol Biol; 2004; 252():385-98. PubMed ID: 15017065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNase P ribozymes for the studies and treatment of human cytomegalovirus infections.
    Trang P; Kilani A; Lee J; Hsu A; Liou K; Kim J; Nassi A; Kim K; Liu F
    J Clin Virol; 2002 Aug; 25 Suppl 2():S63-74. PubMed ID: 12361758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1.
    Trang P; Kilani A; Kim J; Liu F
    J Mol Biol; 2000 Aug; 301(4):817-26. PubMed ID: 10966788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UV cross-link mapping of the substrate-binding site of an RNase P ribozyme to a target mRNA sequence.
    Kilani AF; Liu F
    RNA; 1999 Sep; 5(9):1235-47. PubMed ID: 10496224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro selection of RNase P ribozymes that efficiently cleave a target mRNA.
    Kim K; Liu F
    Methods Mol Biol; 2004; 252():399-412. PubMed ID: 15017066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the regions of RNase P catalytic RNA that are potentially in close contact with its protein cofactor.
    Trang P; Liu F
    Methods Mol Biol; 2008; 488():267-77. PubMed ID: 18982298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of novel catalytic activity by the M1 RNA ribozyme: the cost of molecular adaptation.
    Cole KB; Dorit RL
    J Mol Biol; 1999 Oct; 292(4):931-44. PubMed ID: 10525416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of the in vitro antiviral activity of an engineered M1GS ribozyme that targets to the core gene of hepatitis C virus].
    Zhang W; Li X; Luo G; Huang Z; Liu Y
    Wei Sheng Wu Xue Bao; 2013 Aug; 53(8):875-81. PubMed ID: 24341280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme.
    Trang P; Lee J; Kilani AF; Kim J; Liu F
    Nucleic Acids Res; 2001 Dec; 29(24):5071-8. PubMed ID: 11812839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hepatitis C virus by an M1GS ribozyme derived from the catalytic RNA subunit of Escherichia coli RNase P.
    Mao X; Li X; Mao X; Huang Z; Zhang C; Zhang W; Wu J; Li G
    Virol J; 2014 May; 11():86. PubMed ID: 24885776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Amplification and Selection of Engineered RNase P Ribozyme for Gene Targeting Applications.
    Trang P; Zhang I; Liu F
    Methods Mol Biol; 2024; 2822():419-429. PubMed ID: 38907932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of RNase P Ribozyme Regions in Proximity with a Human RNase P Subunit Protein Using Fe(II)-EDTA Cleavage and Nuclease Footprint Analyses.
    Trang P; Smith A; Liu F
    Methods Mol Biol; 2023; 2666():55-67. PubMed ID: 37166656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.